home / stock / mnmd / mnmd articles

MNMD Articles, Mind Medicine (MindMed) Inc. - From 09/21/23

Stock Information
Company Name: Mind Medicine (MindMed) Inc.
Stock Symbol: MNMD
Market: NASDAQ
Website: mindmed.co
Menu
MNMD MNMD Quote MNMD Short MNMD News MNMD Articles MNMD Message Board
Get MNMD Alerts

News, Short Squeeze, Breakout and More Instantly...
How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space | Benzinga

Artificial Intelligence (AI) is rapidly penetrating a number of different sectors, including healthcare. The use of AI in mental health has opened ...
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More | Benzinga

Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next MAPS Public Benefit Corporation (MAPS PBC), the nonprofi...

Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update | Benzinga

Billionaire hedge fund and NY Mets owner, Steve Cohen amped up his support for psychedelics R&D through a new investment of nearly $1...

Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows | Benzinga

Recent peer-reviewed research published in the journal Nature posits that a small dose of MDMA could be helpful against uncomfo...
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years | Benzinga

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035...

MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone | Benzinga

MindMed (NASDAQ: MNMD), a clinical-stage biopharmaceutical company focused on pioneering innovative treatments for brain health disorders,&nbs...

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More | Benzinga

Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassificat...
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More | Benzinga

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Psychedelics biotech Cybin (NYSE: CYBN) and UK-bas...

Psyched: Psilocybin For Gambling Addiction, Ex-NHL's Retreat, Fellini's LSD Creativity, Surveys, Financings & More | Benzinga

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials Starting this October, scientists at Imperial Colle...

Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More | Benzinga

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials Starting this October, scientists at Imperial Colle...
Previous 10 Next 10